pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
TESTOGEL for low ovarian reserve according t…
Approved · small molecule · low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
TESTOGEL for low ovarian reserve according t… for low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Approved
- Modality
- small_molecule
- Indication
- low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
- Status
- active
- Trials
- 1